These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24251374)

  • 1. The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).
    Tobian AA; Fuller AK; Uglik K; Tisch DJ; Borge PD; Benjamin RJ; Ness PM; King KE
    Transfusion; 2014 Jun; 54(6):1523-9; quiz 1522. PubMed ID: 24251374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of apheresis platelet manipulation on corrected count increment.
    Karafin M; Fuller AK; Savage WJ; King KE; Ness PM; Tobian AA
    Transfusion; 2012 Jun; 52(6):1221-7. PubMed ID: 22233358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of adverse reaction rates for PAS C versus plasma platelet units.
    Cohn CS; Stubbs J; Schwartz J; Francis R; Goss C; Cushing M; Shaz B; Mair D; Brantigan B; Heaton WA
    Transfusion; 2014 Aug; 54(8):1927-34. PubMed ID: 24735171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of platelet additive solution-E stored platelet concentrates.
    Spelmink SE; Jager ST; van de Watering L; van der Meer PF; van Gammeren AJ; Wiersum-Osselton JC; Klei TRL; Kerkhoffs JH;
    Transfusion; 2023 Dec; 63(12):2273-2280. PubMed ID: 37909172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction.
    Tobian AA; Savage WJ; Tisch DJ; Thoman S; King KE; Ness PM
    Transfusion; 2011 Aug; 51(8):1676-83. PubMed ID: 21214585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of volume-reduced versus standard HLA/HPA-matched apheresis platelets in alloimmunized adult patients.
    Honohan A; Tomson B; van der Bom J; de Vries R; Brand A
    Transfusion; 2012 Apr; 52(4):742-51. PubMed ID: 21981629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.
    de Wildt-Eggen J; Nauta S; Schrijver JG; van Marwijk Kooy M; Bins M; van Prooijen HC
    Transfusion; 2000 Apr; 40(4):398-403. PubMed ID: 10773049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.
    van Hout FMA; van der Meer PF; Wiersum-Osselton JC; Middelburg RA; Schipperus MR; van der Bom JG; Kerkhoffs JL
    Transfusion; 2018 Apr; 58(4):1021-1027. PubMed ID: 29405304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions.
    Kacker S; Ness PM; Savage WJ; Frick KD; McCullough J; King KE; Tobian AA
    Transfusion; 2013 Nov; 53(11):2609-18. PubMed ID: 23363552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of platelet concentrates suspended in bicarbonated Ringer's solution in children who had platelet transfusion reactions.
    Kobayashi J; Yanagisawa R; Ono T; Tatsuzawa Y; Tokutake Y; Kubota N; Hidaka E; Sakashita K; Kojima S; Shimodaira S; Nakamura T
    Vox Sang; 2018 Feb; 113(2):128-135. PubMed ID: 29067694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions.
    Drawz SM; Marschner S; Yañez M; García de Coca A; Feys HB; Deeren D; Coene J
    Transfusion; 2015 Jul; 55(7):1745-51. PubMed ID: 25702711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.
    Sigle JP; Infanti L; Studt JD; Martinez M; Stern M; Gratwohl A; Passweg J; Tichelli A; Buser AS
    Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the US hemovigilance reporting system.
    Li N; Williams L; Zhou Z; Wu Y
    Transfusion; 2014 Jun; 54(6):1666-72. PubMed ID: 24410992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransfusion platelet increments after different platelet products in neonates: a retrospective cohort study.
    Honohan A; van't Ende E; Hulzebos C; Lopriore E; van't Verlaat E; Govaert P; Brand A; van der Bom J
    Transfusion; 2013 Dec; 53(12):3100-9. PubMed ID: 23441721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
    Karafin MS; Blagg L; Tobian AA; King KE; Ness PM; Savage WJ
    Transfusion; 2012 Oct; 52(10):2087-93. PubMed ID: 22339320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replaced platelet concentrates containing a new additive solution, M-sol: safety and efficacy for pediatric patients.
    Yanagisawa R; Shimodaira S; Kojima S; Nakasone N; Ishikawa S; Momose K; Honda T; Yoshikawa K; Saito S; Tanaka M; Nakazawa Y; Sakashita K; Shiohara M; Akino M; Hirayama J; Azuma H; Koike K
    Transfusion; 2013 Sep; 53(9):2053-60. PubMed ID: 23252617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS-A in adult patients.
    Yamanaka M; Yanagisawa R; Kojima S; Nakazawa H; Shimodaira S
    Transfusion; 2019 Nov; 59(11):3405-3412. PubMed ID: 31532542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of administration of platelet concentrates suspended in M-sol or BRS-A for pediatric patients.
    Kojima S; Yanagisawa R; Tanaka M; Nakazawa Y; Shimodaira S
    Transfusion; 2018 Dec; 58(12):2952-2958. PubMed ID: 30291756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes.
    Savage WJ; Tobian AA; Fuller AK; Wood RA; King KE; Ness PM
    Transfusion; 2011 Aug; 51(8):1716-22. PubMed ID: 21214586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.